稳健医疗：目前“人造血管项目”计划进入动物试验阶段

Group 1 - The core issue raised by investors is the shift in the development stage of the artificial blood vessel project from "human trials" to "animal trials" after the collaboration with Wuhan Textile University in June 2023 [1] - The company, Steady Medical (300888.SZ), confirmed on September 23 that the artificial blood vessel project is planned to enter the animal trial phase, indicating a longer research and development cycle [1] - The company stated that any significant progress in the project will be communicated to the market in a timely manner [1]